Josef Matyk

The Oriented Development of Antituberculotics. Part 2. Halogenated 3‐(4‐Alkylphenyl)‐1,3‐benzoxazine‐2,4‐(3H)‐diones.

J. Kuneš, K. Waisser, K. Palat, 2007 .

The Oriented Development of Antituberculotics (Part II): Halogenated 3‐(4‐Alkylphenyl)‐1,3‐benzoxazine‐2,4‐(3H)‐diones

J. Kuneš, K. Waisser, K. Palat, 2007, Archiv der Pharmazie.

Heterocyclic isosters of antimycobacterial salicylanilides.

J. Kuneš, K. Waisser, K. Palat, 2005, Farmaco.